Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
NextCure
company
About
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $67M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$160M
NextCure has raised a total of
$160M
in funding over 2 rounds. Their latest funding was raised on
Nov 13, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 13, 2018 | Series B | $93M | 2 | — | — | Detail |
| Jan 6, 2016 | Series A | $67M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
NextCure is funded by 2 investors.
Pfizer
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pfizer
|
— | Series B |
Lilly Asia Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
